ArticleVeterinary sciences2025
SOX Family Members Expression in Canine Oral Melanoma: Role of the SOX3 in Tumor Aggressiveness.
Article in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aggressiveness of oral melanoma can be related to several mutations that occur during development. Based on the knowledge of the role of transcription factors of the SOX family in other neoplastic types, it is necessary to understand their behavior in oral melanomas. In this work, the expression of SOX2, SOX3, and SOX10 and its relationship with the proliferative index and histological aspects indicative of aggressiveness in canine oral melanomas were evaluated. Thirty tumors were histologically reviewed and the expression of Melan-A, SOX2, SOX3, SOX10, and Ki67 in these tumors were determined. All tumors presented histomorphological characteristics compatible with malignant tumors and immunopositivity for Melan-A. The expression of SOX2, SOX3, and SOX10 was observed in 7/30 (23.3%), 6/30 (20%), and 23/30 (76.6%) of the cases, respectively. Among the analyzed markers, the relationship between the loss of SOX3 expression in tumors with higher proliferative rates was highlighted. An inverse correlation was also observed between the expression cytoplasmic SOX10 and nuclear SOX10, suggesting a change in the location of this protein in oral melanomas. Among the SOX family proteins studied, the SOX3 protein plays a role in the regulation of cell proliferation in oral melanomas, and it is suggested that the SOX2 and SOX10 proteins are constitutively expressed in these neoplasms, without a determining role for aggressiveness. New studies of this gene transcription pathway may assist in possible prognostic and predictive determinations of the SOX3 protein in oral canine melanoma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.